BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 427771)

  • 1. Risk assessment of
    ; Schrenk D; Bignami M; Bodin L; Chipman JK; Del Mazo J; Hogstrand C; Ron Hoogenboom L; Leblanc JC; Nebbia CS; Nielsen E; Ntzani E; Petersen A; Sand S; Schwerdtle T; Vleminckx C; Wallace H; Romualdo B; Cristina F; Stephen H; Marco I; Mosbach-Schulz O; Riolo F; Christodoulidou A; Grasl-Kraupp B
    EFSA J; 2023 Mar; 21(3):e07884. PubMed ID: 36999063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Activation and DNA Interactions of Carcinogenic
    Li Y; Hecht SS
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trapping of a cross-link formed by a major purine adduct of a metabolite of the carcinogen N-nitrosomorpholine by inorganic and biological reductants.
    Koissi N; Fishbein JC
    Chem Res Toxicol; 2013 May; 26(5):732-40. PubMed ID: 23587048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and simple method for the determination of volatile N-nitrosamines in biological materials.
    Maki T
    Bull Environ Contam Toxicol; 1980 Nov; 25(5):751-4. PubMed ID: 7470650
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of selected drug formulations for volatile nitrosamines.
    Dawson BA; Lawrence RC
    J Assoc Off Anal Chem; 1987; 70(3):554-6. PubMed ID: 3610969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosamines in new automobiles.
    Fine DH; Reisch J; Rounbehler DP
    IARC Sci Publ; 1980; (31):541-54. PubMed ID: 7228278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary levels of N-nitrosamines and some metabolites after IP injection of N-nitrosamines in rats.
    Fliessbach JH; Guttenplan JB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):283-91. PubMed ID: 7302376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of N-nitrosamines in gastric juice and urine and a comparison of endogenous formation of N-nitrosoproline and its inhibition in subjects from high- and low-risk areas for oesophageal cancer.
    Lu SH; Yang WX; Guo LP; Li FM; Wang GJ; Zhang JS; Li PZ
    IARC Sci Publ; 1987; (84):538-43. PubMed ID: 3679439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of urinary volatile nitrosamines from exposure to tobacco smoke.
    Seyler TH; Kim JG; Hodgson JA; Cowan EA; Blount BC; Wang L
    J Anal Toxicol; 2013 May; 37(4):195-202. PubMed ID: 23508653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview: dialkylnitrosamine bioactivation and carcinogenesis.
    Lai DY; Arcos JC
    Life Sci; 1980 Dec; 27(23):2149-65. PubMed ID: 7010036
    [No Abstract]   [Full Text] [Related]  

  • 11. Volatile N-nitrosamines in the urine of normal donors and of bladder cancer patients.
    Kakizoe T; Wang TT; Eng VW; Furrer R; Dion P; Bruce WR
    Cancer Res; 1979 Mar; 39(3):829-32. PubMed ID: 427771
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.